Prescription Error: A Case of Metronidazole-Induced Pancreatitis

Introduction: Metronidazole is a nitroimidazole antibacterial drug that is mostly used to treat anaerobic bacteria and protozoa infections. The adverse side effects of metronidazole include gastrointestinal upset, metallic taste, urticaria, headache, peripheral neuropathy. Metronidazole-induced panc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug safety 2022-10, Vol.45 (10), p.1136-1136
Hauptverfasser: Daldoul, M, Hamza, I, Zaiem, A, Mahjoubi, Y, Kaabi, W, Jabri, F E, Daghfous, R, El Aidli, S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1136
container_issue 10
container_start_page 1136
container_title Drug safety
container_volume 45
creator Daldoul, M
Hamza, I
Zaiem, A
Mahjoubi, Y
Kaabi, W
Jabri, F E
Daghfous, R
El Aidli, S
description Introduction: Metronidazole is a nitroimidazole antibacterial drug that is mostly used to treat anaerobic bacteria and protozoa infections. The adverse side effects of metronidazole include gastrointestinal upset, metallic taste, urticaria, headache, peripheral neuropathy. Metronidazole-induced pancreatitis has been rarely described in the literature so far. Objective: We report a rare case of an acute pancreatitis associated with metronidazole which occurred as a result of a prescription error. Methods: This case was reported in February 2022 to The National Centre of Pharmacovigilance and evaluated according to the updated French method of causality assessment. Results: A 70-year-old male patient with a past medical history of chronic viral hepatitis B treated with entecavir since 2006, presented to the surgery department with an acute onset of a severe epigastric pain radiating through to the back associated with hepatic colic with nausea and vomiting. Symptoms started 7 days after initiation of metronidazole given by the patients dentist for treatment of a periodontal abscess. Metronidazole was prescribed twice under two different trade names Birodogyl (spiramycine, metronidazole) and Tamizol(metronidazole) medications. On exam, he had severe epigastric tenderness. Biochemical analysis showed lipase 632 U/L (6N), and amylase 322 U/L (3N). The abdominal CT scan showed an aspect of acute oedemato-interstitial pancreatitis stage B (CSTI 1). Relative negatives in the history included, no lithiasis, no known drug allergies, and no alcohol consumption. Patient symptoms and lipase improved within 3 days after metronidazole withdrawl and initiation of supportive care. Conclusion: The likelihood of metronidazole as the incriminating agent was likely in front of a suggestive delay and favorable outcome after the drug withdrawl. It was suggested a the possible dose-response mechanism between metronidazole use and occurrence of pancreatitis, and this case draw attention to the possible acute pancreatitis associated with metronidazole due to a prescription error.
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2718387855</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2718387855</sourcerecordid><originalsourceid>FETCH-proquest_journals_27183878553</originalsourceid><addsrcrecordid>eNqNyrsKwjAUgOEgCtbLOwScA0mvqZNSFB2EDu4ltKeQUnLqSbr49Dr4AE7_8P0LFilVlEKVabxkkVQqFVmp8jXbeD9IKXWc64idagLfkp2CRccvREhHfuaV8cCx5w8IhM525o0jiLvr5hY6XhvXEphgg_U7turN6GH_65YdrpdndRMT4WsGH5oBZ3JfauJC6UQXOsuS_64PDi46Ow</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2718387855</pqid></control><display><type>article</type><title>Prescription Error: A Case of Metronidazole-Induced Pancreatitis</title><source>SpringerLink Journals - AutoHoldings</source><creator>Daldoul, M ; Hamza, I ; Zaiem, A ; Mahjoubi, Y ; Kaabi, W ; Jabri, F E ; Daghfous, R ; El Aidli, S</creator><creatorcontrib>Daldoul, M ; Hamza, I ; Zaiem, A ; Mahjoubi, Y ; Kaabi, W ; Jabri, F E ; Daghfous, R ; El Aidli, S</creatorcontrib><description>Introduction: Metronidazole is a nitroimidazole antibacterial drug that is mostly used to treat anaerobic bacteria and protozoa infections. The adverse side effects of metronidazole include gastrointestinal upset, metallic taste, urticaria, headache, peripheral neuropathy. Metronidazole-induced pancreatitis has been rarely described in the literature so far. Objective: We report a rare case of an acute pancreatitis associated with metronidazole which occurred as a result of a prescription error. Methods: This case was reported in February 2022 to The National Centre of Pharmacovigilance and evaluated according to the updated French method of causality assessment. Results: A 70-year-old male patient with a past medical history of chronic viral hepatitis B treated with entecavir since 2006, presented to the surgery department with an acute onset of a severe epigastric pain radiating through to the back associated with hepatic colic with nausea and vomiting. Symptoms started 7 days after initiation of metronidazole given by the patients dentist for treatment of a periodontal abscess. Metronidazole was prescribed twice under two different trade names Birodogyl (spiramycine, metronidazole) and Tamizol(metronidazole) medications. On exam, he had severe epigastric tenderness. Biochemical analysis showed lipase 632 U/L (6N), and amylase 322 U/L (3N). The abdominal CT scan showed an aspect of acute oedemato-interstitial pancreatitis stage B (CSTI 1). Relative negatives in the history included, no lithiasis, no known drug allergies, and no alcohol consumption. Patient symptoms and lipase improved within 3 days after metronidazole withdrawl and initiation of supportive care. Conclusion: The likelihood of metronidazole as the incriminating agent was likely in front of a suggestive delay and favorable outcome after the drug withdrawl. It was suggested a the possible dose-response mechanism between metronidazole use and occurrence of pancreatitis, and this case draw attention to the possible acute pancreatitis associated with metronidazole due to a prescription error.</description><identifier>ISSN: 0114-5916</identifier><identifier>EISSN: 1179-1942</identifier><language>eng</language><publisher>Auckland: Springer Nature B.V</publisher><subject>Allergies ; Anaerobic bacteria ; Anaerobic treatment ; Antiinfectives and antibacterials ; Biochemical analysis ; Colic ; Computed tomography ; Errors ; Headache ; Hepatitis B ; Lipase ; Lithiasis ; Metronidazole ; Nausea ; Nitroimidazole ; Pain ; Pancreatitis ; Patients ; Peripheral neuropathy ; Pharmacovigilance ; Protozoa ; Side effects ; Urticaria ; Vomiting</subject><ispartof>Drug safety, 2022-10, Vol.45 (10), p.1136-1136</ispartof><rights>Copyright Springer Nature B.V. Oct 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782</link.rule.ids></links><search><creatorcontrib>Daldoul, M</creatorcontrib><creatorcontrib>Hamza, I</creatorcontrib><creatorcontrib>Zaiem, A</creatorcontrib><creatorcontrib>Mahjoubi, Y</creatorcontrib><creatorcontrib>Kaabi, W</creatorcontrib><creatorcontrib>Jabri, F E</creatorcontrib><creatorcontrib>Daghfous, R</creatorcontrib><creatorcontrib>El Aidli, S</creatorcontrib><title>Prescription Error: A Case of Metronidazole-Induced Pancreatitis</title><title>Drug safety</title><description>Introduction: Metronidazole is a nitroimidazole antibacterial drug that is mostly used to treat anaerobic bacteria and protozoa infections. The adverse side effects of metronidazole include gastrointestinal upset, metallic taste, urticaria, headache, peripheral neuropathy. Metronidazole-induced pancreatitis has been rarely described in the literature so far. Objective: We report a rare case of an acute pancreatitis associated with metronidazole which occurred as a result of a prescription error. Methods: This case was reported in February 2022 to The National Centre of Pharmacovigilance and evaluated according to the updated French method of causality assessment. Results: A 70-year-old male patient with a past medical history of chronic viral hepatitis B treated with entecavir since 2006, presented to the surgery department with an acute onset of a severe epigastric pain radiating through to the back associated with hepatic colic with nausea and vomiting. Symptoms started 7 days after initiation of metronidazole given by the patients dentist for treatment of a periodontal abscess. Metronidazole was prescribed twice under two different trade names Birodogyl (spiramycine, metronidazole) and Tamizol(metronidazole) medications. On exam, he had severe epigastric tenderness. Biochemical analysis showed lipase 632 U/L (6N), and amylase 322 U/L (3N). The abdominal CT scan showed an aspect of acute oedemato-interstitial pancreatitis stage B (CSTI 1). Relative negatives in the history included, no lithiasis, no known drug allergies, and no alcohol consumption. Patient symptoms and lipase improved within 3 days after metronidazole withdrawl and initiation of supportive care. Conclusion: The likelihood of metronidazole as the incriminating agent was likely in front of a suggestive delay and favorable outcome after the drug withdrawl. It was suggested a the possible dose-response mechanism between metronidazole use and occurrence of pancreatitis, and this case draw attention to the possible acute pancreatitis associated with metronidazole due to a prescription error.</description><subject>Allergies</subject><subject>Anaerobic bacteria</subject><subject>Anaerobic treatment</subject><subject>Antiinfectives and antibacterials</subject><subject>Biochemical analysis</subject><subject>Colic</subject><subject>Computed tomography</subject><subject>Errors</subject><subject>Headache</subject><subject>Hepatitis B</subject><subject>Lipase</subject><subject>Lithiasis</subject><subject>Metronidazole</subject><subject>Nausea</subject><subject>Nitroimidazole</subject><subject>Pain</subject><subject>Pancreatitis</subject><subject>Patients</subject><subject>Peripheral neuropathy</subject><subject>Pharmacovigilance</subject><subject>Protozoa</subject><subject>Side effects</subject><subject>Urticaria</subject><subject>Vomiting</subject><issn>0114-5916</issn><issn>1179-1942</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNyrsKwjAUgOEgCtbLOwScA0mvqZNSFB2EDu4ltKeQUnLqSbr49Dr4AE7_8P0LFilVlEKVabxkkVQqFVmp8jXbeD9IKXWc64idagLfkp2CRccvREhHfuaV8cCx5w8IhM525o0jiLvr5hY6XhvXEphgg_U7turN6GH_65YdrpdndRMT4WsGH5oBZ3JfauJC6UQXOsuS_64PDi46Ow</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Daldoul, M</creator><creator>Hamza, I</creator><creator>Zaiem, A</creator><creator>Mahjoubi, Y</creator><creator>Kaabi, W</creator><creator>Jabri, F E</creator><creator>Daghfous, R</creator><creator>El Aidli, S</creator><general>Springer Nature B.V</general><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7T2</scope><scope>7TK</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20221001</creationdate><title>Prescription Error: A Case of Metronidazole-Induced Pancreatitis</title><author>Daldoul, M ; Hamza, I ; Zaiem, A ; Mahjoubi, Y ; Kaabi, W ; Jabri, F E ; Daghfous, R ; El Aidli, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_27183878553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Allergies</topic><topic>Anaerobic bacteria</topic><topic>Anaerobic treatment</topic><topic>Antiinfectives and antibacterials</topic><topic>Biochemical analysis</topic><topic>Colic</topic><topic>Computed tomography</topic><topic>Errors</topic><topic>Headache</topic><topic>Hepatitis B</topic><topic>Lipase</topic><topic>Lithiasis</topic><topic>Metronidazole</topic><topic>Nausea</topic><topic>Nitroimidazole</topic><topic>Pain</topic><topic>Pancreatitis</topic><topic>Patients</topic><topic>Peripheral neuropathy</topic><topic>Pharmacovigilance</topic><topic>Protozoa</topic><topic>Side effects</topic><topic>Urticaria</topic><topic>Vomiting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Daldoul, M</creatorcontrib><creatorcontrib>Hamza, I</creatorcontrib><creatorcontrib>Zaiem, A</creatorcontrib><creatorcontrib>Mahjoubi, Y</creatorcontrib><creatorcontrib>Kaabi, W</creatorcontrib><creatorcontrib>Jabri, F E</creatorcontrib><creatorcontrib>Daghfous, R</creatorcontrib><creatorcontrib>El Aidli, S</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Drug safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Daldoul, M</au><au>Hamza, I</au><au>Zaiem, A</au><au>Mahjoubi, Y</au><au>Kaabi, W</au><au>Jabri, F E</au><au>Daghfous, R</au><au>El Aidli, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prescription Error: A Case of Metronidazole-Induced Pancreatitis</atitle><jtitle>Drug safety</jtitle><date>2022-10-01</date><risdate>2022</risdate><volume>45</volume><issue>10</issue><spage>1136</spage><epage>1136</epage><pages>1136-1136</pages><issn>0114-5916</issn><eissn>1179-1942</eissn><abstract>Introduction: Metronidazole is a nitroimidazole antibacterial drug that is mostly used to treat anaerobic bacteria and protozoa infections. The adverse side effects of metronidazole include gastrointestinal upset, metallic taste, urticaria, headache, peripheral neuropathy. Metronidazole-induced pancreatitis has been rarely described in the literature so far. Objective: We report a rare case of an acute pancreatitis associated with metronidazole which occurred as a result of a prescription error. Methods: This case was reported in February 2022 to The National Centre of Pharmacovigilance and evaluated according to the updated French method of causality assessment. Results: A 70-year-old male patient with a past medical history of chronic viral hepatitis B treated with entecavir since 2006, presented to the surgery department with an acute onset of a severe epigastric pain radiating through to the back associated with hepatic colic with nausea and vomiting. Symptoms started 7 days after initiation of metronidazole given by the patients dentist for treatment of a periodontal abscess. Metronidazole was prescribed twice under two different trade names Birodogyl (spiramycine, metronidazole) and Tamizol(metronidazole) medications. On exam, he had severe epigastric tenderness. Biochemical analysis showed lipase 632 U/L (6N), and amylase 322 U/L (3N). The abdominal CT scan showed an aspect of acute oedemato-interstitial pancreatitis stage B (CSTI 1). Relative negatives in the history included, no lithiasis, no known drug allergies, and no alcohol consumption. Patient symptoms and lipase improved within 3 days after metronidazole withdrawl and initiation of supportive care. Conclusion: The likelihood of metronidazole as the incriminating agent was likely in front of a suggestive delay and favorable outcome after the drug withdrawl. It was suggested a the possible dose-response mechanism between metronidazole use and occurrence of pancreatitis, and this case draw attention to the possible acute pancreatitis associated with metronidazole due to a prescription error.</abstract><cop>Auckland</cop><pub>Springer Nature B.V</pub></addata></record>
fulltext fulltext
identifier ISSN: 0114-5916
ispartof Drug safety, 2022-10, Vol.45 (10), p.1136-1136
issn 0114-5916
1179-1942
language eng
recordid cdi_proquest_journals_2718387855
source SpringerLink Journals - AutoHoldings
subjects Allergies
Anaerobic bacteria
Anaerobic treatment
Antiinfectives and antibacterials
Biochemical analysis
Colic
Computed tomography
Errors
Headache
Hepatitis B
Lipase
Lithiasis
Metronidazole
Nausea
Nitroimidazole
Pain
Pancreatitis
Patients
Peripheral neuropathy
Pharmacovigilance
Protozoa
Side effects
Urticaria
Vomiting
title Prescription Error: A Case of Metronidazole-Induced Pancreatitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T02%3A45%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prescription%20Error:%20A%20Case%20of%20Metronidazole-Induced%20Pancreatitis&rft.jtitle=Drug%20safety&rft.au=Daldoul,%20M&rft.date=2022-10-01&rft.volume=45&rft.issue=10&rft.spage=1136&rft.epage=1136&rft.pages=1136-1136&rft.issn=0114-5916&rft.eissn=1179-1942&rft_id=info:doi/&rft_dat=%3Cproquest%3E2718387855%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2718387855&rft_id=info:pmid/&rfr_iscdi=true